Ivor-Lewis oesophagectomy for oesophageal adenocarcinoma after orthotopic liver transplant: an update
Letter to the Editor

Ivor-Lewis oesophagectomy for oesophageal adenocarcinoma after orthotopic liver transplant: an update

Adam Frankel1,2

1Princess Alexandra Hospital, Brisbane, Australia; 2Discipline of Surgery, University of Queensland, Brisbane, Australia

Correspondence to: Dr. Adam Frankel. Level 4, Building 1, Princess Alexandra Hospital, Ipswich Rd, Woolloongabba 4102, Brisbane, Australia. Email: a.frankel@uq.edu.au.

Comment on: Thatcher K, Frankel A, O’Rourke T, et al. Ivor-Lewis oesophagectomy for oesophageal adenocarcinoma after orthotopic liver transplant: a case report. Dig Med Res 2021;4:19.


Received: 18 May 2022; Accepted: 27 July 2022; Published: 30 September 2022.

doi: 10.21037/dmr-22-39


I write to update you on the status of the patient presented as a case report entitled “Ivor-Lewis oesophagectomy for oesophageal adenocarcinoma after orthotopic liver transplant: a case report” by Thatcher et al., which is published in your journal (1).

His clinical stage was cT3N0M0. After neoadjuvant chemo-radiotherapy (CROSS protocol), he underwent an Ivor Lewis oesophagectomy. His pathological stage was ypT0N0 (complete pathological response). He was investigated for cough and dyspnoea 15 months post-resection and was found to have a malignant pleural effusion. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) did not show any other disease. He underwent aspiration and talc pleurodesis. He declined palliative chemotherapy and remains asymptomatic 10 months later.

This case highlights the complex considerations of solid-organ malignancy in liver transplant recipients.


Acknowledgments

Funding: None.


Footnote

Provenance and Peer Review: This article was a standard submission to the journal. The article has undergone external peer review.

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://dmr.amegroups.com/article/view/10.21037/dmr-22-39/coif). The author has no conflicts of interest to declare.

Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Thatcher K, Frankel A, O’Rourke T, et al. Ivor-Lewis oesophagectomy for oesophageal adenocarcinoma after orthotopic liver transplant: a case report. Dig Med Res 2021;4:19. [Crossref]
doi: 10.21037/dmr-22-39
Cite this article as: Frankel A. Ivor-Lewis oesophagectomy for oesophageal adenocarcinoma after orthotopic liver transplant: an update. Dig Med Res 2022;5:49.

Download Citation